<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37239511</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5782</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph20105782</ELocationID><Abstract><AbstractText>(1) Background: Immunological laboratory testing is known to be complex, and it is usually performed in tertiary referral centers. Many criticalities affect diagnostic immunological testing, such as limited availability, the need for specifically trained laboratory staff, and potential difficulties in collecting blood samples, especially in the most vulnerable patients, i.e., the elderly and children. For this reason, the identification of a new feasible and reliable methodology for autoantibody detection is urgently needed. (2) Methods: We designed a systematic review to investigate the available literature on the utilization of saliva samples for immunological testing. (3) Results: A total of 170 articles were identified. Eighteen studies met the inclusion criteria, accounting for 1059 patients and 671 controls. The saliva collection method was mostly represented by passive drooling (11/18, 61%), and the most frequently described methodology for antibody detection was ELISA (12/18, 67%). The analysis included 392 patients with rheumatoid arthritis, 161 with systemic lupus erythematosus, 131 with type 1 diabetes mellitus, 116 with primary biliary cholangitis, 100 with pemphigus vulgaris, 50 with bullous pemphigoids, 49 with Sjogren syndrome, 39 with celiac disease, 10 with primary antiphospholipid syndromes, 8 with undifferentiated connective tissue disease, 2 with systemic sclerosis, and 1 with autoimmune thyroiditis. The majority of the reviewed studies involved adequate controls, and saliva testing allowed for a clear distinction of patients (10/12 studies, 83%). More than half of the papers showed a correlation between saliva and serum results (10/18, 55%) for autoantibody detection, with varying rates of correlation, sensitivity, and specificity. Interestingly, many papers showed a correlation between saliva antibody results and clinical manifestations. (4) Conclusions: Saliva testing might represent an appealing alternative to serum-based testing for autoantibody detection, considering the correspondence with serum testing results and the correlation with clinical manifestations. Nonetheless, standardization of sample collection processing, maintenance, and detection methodology has yet to be fully addressed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Foddai</LastName><ForeName>Silvia Grazietta</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, University of Turin, 10124 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radin</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1941-2606</Identifier><AffiliationInfo><Affiliation>University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, University of Turin, 10124 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barinotti</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchi</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, University of Turin, 10124 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubini</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbrile</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, University of Turin, 10124 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantello</LastName><ForeName>Ester</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menegatti</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7849-6323</Identifier><AffiliationInfo><Affiliation>University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, University of Turin, 10124 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roccatello</LastName><ForeName>Dario</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4419-6813</Identifier><AffiliationInfo><Affiliation>University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, University of Turin, 10124 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sciascia</LastName><ForeName>Savino</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1266-9441</Identifier><AffiliationInfo><Affiliation>University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, University of Turin, 10124 Turin, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012463" MajorTopicYN="N">Saliva</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmune disorders</Keyword><Keyword MajorTopicYN="N">saliva</Keyword><Keyword MajorTopicYN="N">testing feasibility</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37239511</ArticleId><ArticleId IdType="pmc">PMC10218106</ArticleId><ArticleId IdType="doi">10.3390/ijerph20105782</ArticleId><ArticleId IdType="pii">ijerph20105782</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pfaffe T., Cooper-White J., Beyerlein P., Kostner K., Punyadeera C. Diagnostic potential of saliva: Current state and future ap-plications. Clin. Chem. 2011;57:675&#x2013;687. doi: 10.1373/clinchem.2010.153767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2010.153767</ArticleId><ArticleId IdType="pubmed">21383043</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortimer P.P., Parry J.V. Detection of antibody to HIV in saliva: A brief review. Clin. Diagn. Virol. 1994;2:231&#x2013;243. doi: 10.1016/0928-0197(94)90048-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0928-0197(94)90048-5</ArticleId><ArticleId IdType="pubmed">15566769</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan D.B., Mackett K., Ali M.U., Yamamura D., Balion C. Performance of saliva compared with nasopharyngeal swab for diagnosis of COVID-19 by NAAT in cross-sectional studies: Systematic review and meta-analysis. Clin. Biochem. 2023;117:84&#x2013;93. doi: 10.1016/j.clinbiochem.2022.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2022.08.004</ArticleId><ArticleId IdType="pmc">PMC9359767</ArticleId><ArticleId IdType="pubmed">35952732</ArticleId></ArticleIdList></Reference><Reference><Citation>Hema Shree K., Ramani P., Sherlin H., Sukumaran G., Jeyaraj G., Don K.R., Santhanam A., Ramasubramanian A., Sundar R. Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma&#x2014;A Systematic Review with Meta Analysis. Pathol. Oncol. Res. 2019;25:447&#x2013;453. doi: 10.1007/s12253-019-00588-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12253-019-00588-2</ArticleId><ArticleId IdType="pubmed">30712193</ArticleId></ArticleIdList></Reference><Reference><Citation>Goud E.V., Kannan R., Rao U., Joshua E., Tavaraja R., Jain Y. Identification of Helicobacter pylori in Saliva of Patients with and without Gastritis by Polymerase Chain Reaction. J. Pharm. Bioallied Sci. Wolters Kluwer Medknow Publ. 2019;11:S523. doi: 10.4103/jpbs.JPBS_260_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jpbs.JPBS_260_18</ArticleId><ArticleId IdType="pmc">PMC6896576</ArticleId><ArticleId IdType="pubmed">31920269</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi M.R., Tecco S., Gastaldi G., Polizzi E., D&#x2019;Amicantonio T., Negri S., Gardini I., Schlusnus K., Gherlone E., Cappar&#xe8; P., et al. Point-of-care testing for hepatitis C virus infection at alternative and high-risk sites: An Italian pilot study in a dental clinic. New Microbiol. 2017;40:242&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">28825443</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith D.H., Raslan S., Samuels M.A., Bs T.I., Buitron I., Deo S., Daunert S., Thomas G.R., Califano J., Franzmann E.J. Current salivary biomarkers for detection of human papilloma virus-induced oropharyngeal squamous cell carcinoma. Head Neck. 2021;43:3618&#x2013;3630. doi: 10.1002/hed.26830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.26830</ArticleId><ArticleId IdType="pubmed">34331493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastin P., Maiter D., Gruson D. Salivary cortisol testing: Preanalytic and analytic aspects. Ann. De Biol. Clin. 2018;76:393&#x2013;405. doi: 10.1684/abc.2018.1355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/abc.2018.1355</ArticleId><ArticleId IdType="pubmed">29952304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundberg I., Rasmusson A., Ramklint M., Just D., Ekselius L., Cunningham J.L. Daytime melatonin levels in saliva are associated with inflammatory markers and anxiety disorders. Psychoneuroendocrinology. 2020;112:104514. doi: 10.1016/j.psyneuen.2019.104514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2019.104514</ArticleId><ArticleId IdType="pubmed">31776047</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Qiu X., Wang D., Li Y., Zong Y., Liu Y., Zhang Y., Yang P., Zuo Y., Yang H., et al. Quantification of 10 steroid hormones in human saliva from Chinese adult volunteers. J. Int. Med. Res. 2018;46:1414&#x2013;1427. doi: 10.1177/0300060517752733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060517752733</ArticleId><ArticleId IdType="pmc">PMC6091835</ArticleId><ArticleId IdType="pubmed">29468906</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues R.P.C.B., Vieira W.D.A., Siqueira W.L., Blumenberg C., Bernardino D.M., Cardoso S.V., Flores-Mir C., Paranhos L.R. Saliva as an alternative to blood in the determination of uremic state in adult patients with chronic kidney disease: A systematic review and meta-analysis. Clin. Oral Investig. 2020;24:2203&#x2013;2217. doi: 10.1007/s00784-020-03340-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-020-03340-2</ArticleId><ArticleId IdType="pubmed">32447524</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuttolomondo D., Antonelli R., Setti G., Ardissino D., Pertinhez T., Gallo M., Niccoli G., Nicolini F., Georgaki M., Formica F., et al. Salivary biomarkers for diagnosis of acute myocardial infarction: A systematic review. Int. J. Cardiol. 2023;371:54&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">36167219</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolgin M., Zobernig M., Dvornyk V., Braun R.J., Kielbassa A.M. Systematic Review on Saliva Biomarkers in Patients Diagnosed with Morbus Alzheimer and Morbus Parkinson. Biomedicines. 2022;10:1702. doi: 10.3390/biomedicines10071702.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10071702</ArticleId><ArticleId IdType="pmc">PMC9313191</ArticleId><ArticleId IdType="pubmed">35885007</ArticleId></ArticleIdList></Reference><Reference><Citation>Naing C., Mak J.W. Salivary glucose in monitoring glycaemia in patients with type 1 diabetes mellitus: A systematic review. J. Diabetes Metab. Disord. 2017;16:2. doi: 10.1186/s40200-017-0287-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40200-017-0287-5</ArticleId><ArticleId IdType="pmc">PMC5251294</ArticleId><ArticleId IdType="pubmed">28127542</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias-Bujanda N., Regueira-Iglesias A., Balsa-Castro C., Nibali L., Donos N., Tom&#xe1;s I. Accuracy of single molecular biomarkers in saliva for the diagnosis of periodontitis: A systematic review and meta-analysis. J. Clin. Periodontol. 2020;47:2&#x2013;18. doi: 10.1111/jcpe.13202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.13202</ArticleId><ArticleId IdType="pubmed">31560804</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Sun T., Zhu P., Sun Z., Li S., Li F., Zhang Y., Tan K., Lu J., Yuan R., et al. Quantitative Analysis of Salivary Oral Bacteria Associated with Severe Early Childhood Caries and Construction of Caries Assessment Model. Sci. Rep. 2020;10:6365. doi: 10.1038/s41598-020-63222-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-63222-1</ArticleId><ArticleId IdType="pmc">PMC7156402</ArticleId><ArticleId IdType="pubmed">32286402</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwivedi R., Gupta Y.K., Singh M., Joshi R., Tiwari P., Kaleekal T., Tripathi M. Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy. Seizure. 2015;25:187&#x2013;190. doi: 10.1016/j.seizure.2014.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2014.10.010</ArticleId><ArticleId IdType="pubmed">25455060</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer J.N., Fiorentin T.R., Sousa T.R.V., Limberger R.P., Pechansky F. Oral Fluid Testing for Cocaine: Analytical Evaluation of Two Point-of-Collection Drug Screening Devices. J. Anal. Toxicol. 2017;41:392&#x2013;398. doi: 10.1093/jat/bkx018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jat/bkx018</ArticleId><ArticleId IdType="pubmed">28334841</ArticleId></ArticleIdList></Reference><Reference><Citation>Malamud D., Rodriguez-Chavez I.R. Saliva as a Diagnostic Fluid. Dent. Clin. N. Am. 2011;55:159&#x2013;178. doi: 10.1016/j.cden.2010.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cden.2010.08.004</ArticleId><ArticleId IdType="pmc">PMC3011946</ArticleId><ArticleId IdType="pubmed">21094724</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete A.G. Oral fluid testing for driving under the influence of drugs: History, recent progress and remaining challenges. Forensic Sci. Int. 2005;150:143&#x2013;150. doi: 10.1016/j.forsciint.2004.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.forsciint.2004.11.023</ArticleId><ArticleId IdType="pubmed">15944054</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichardt E.M., Baldwin D., Osselton M.D. Effects of Oral Fluid Contamination on Two Oral Fluid Testing Systems. J. Anal. Toxicol. 2013;37:246&#x2013;249. doi: 10.1093/jat/bkt009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jat/bkt009</ArticleId><ArticleId IdType="pubmed">23471957</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int. J. Surg. 2021;372:105906. doi: 10.1016/j.ijsu.2021.105906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2021.105906</ArticleId><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Du Y., Wu Q., Li H., Nguyen T., Gidley G., Duran V., Goldman D., Petri M., Mohan C. Salivary anti-nuclear antibody (ANA) mirrors serum ANA in systemic lupus erythematosus. Thromb. Haemost. 2022;24:3. doi: 10.1186/s13075-021-02694-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02694-6</ArticleId><ArticleId IdType="pmc">PMC8721993</ArticleId><ArticleId IdType="pubmed">34980255</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciascia S., Bentow C., Radin M., Barinotti A., Cecchi I., Foddai S., Roccatello D., Mahler M. Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients. Diagnostics. 2022;12:2026. doi: 10.3390/diagnostics12082026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12082026</ArticleId><ArticleId IdType="pmc">PMC9407454</ArticleId><ArticleId IdType="pubmed">36010376</ArticleId></ArticleIdList></Reference><Reference><Citation>Ching K.H., Burbelo P.D., Gonzalez-Begne M., Roberts M.E.P., Coca A., Sanz I., Iadarola M.J. Salivary anti-Ro60 and anti-Ro52 an-tibody profiles to diagnose sj&#xf6;gren&#x2019;s syndrome. J. Dent. Res. 2011;90:445&#x2013;449. doi: 10.1177/0022034510390811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034510390811</ArticleId><ArticleId IdType="pmc">PMC3125128</ArticleId><ArticleId IdType="pubmed">21212317</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbelo P., Ferr&#xe9; E., Chaturvedi A., Chiorini J., Alevizos I., Lionakis M., Warner B. Profiling Autoantibodies against Salivary Proteins in Sicca Conditions. J. Dent. Res. 2019;98:772&#x2013;778. doi: 10.1177/0022034519850564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034519850564</ArticleId><ArticleId IdType="pmc">PMC6589895</ArticleId><ArticleId IdType="pubmed">31095438</ArticleId></ArticleIdList></Reference><Reference><Citation>Demoruelle M.K., Wang H., Davis R.L., Visser A., Hoang J., Norris J.M., Holers V.M., Deane K.D., Darrah E. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis. Thromb. Haemost. 2021;23:163. doi: 10.1186/s13075-021-02528-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02528-5</ArticleId><ArticleId IdType="pmc">PMC8182933</ArticleId><ArticleId IdType="pubmed">34092252</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos Ljungberg K., B&#xf6;rjesson E., Martinsson K., Wetter&#xf6; J., Kastbom A., Sv&#xe4;rd A. Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis. Arthritis Res. Ther. 2020;22:274. doi: 10.1186/s13075-020-02363-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-020-02363-0</ArticleId><ArticleId IdType="pmc">PMC7681967</ArticleId><ArticleId IdType="pubmed">33225988</ArticleId></ArticleIdList></Reference><Reference><Citation>Sv&#xe4;rd A., Renvert S., Berglund J.S., Persson R.G., S&#xf6;derlin M. Antibodies to citrullinated peptides in serum and saliva in patients with rheumatoid arthritis and their association to periodontitis. Ann. Rheum. Dis. 2020;38:699&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">31820729</ArticleId></ArticleIdList></Reference><Reference><Citation>Sv&#xe4;rd A., Roos Ljungberg K., Brink M., Martinsson K., Sj&#xf6;wall C., Dahlqvist S.R., Kastbom A. Secretory antibodies to citrul-linated peptides in plasma and saliva from rheumatoid arthritis patients and their unaffected first-degree relatives. Clin. Exp. Immunol. 2020;199:143&#x2013;149. doi: 10.1111/cei.13381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13381</ArticleId><ArticleId IdType="pmc">PMC6954678</ArticleId><ArticleId IdType="pubmed">31605388</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopaie M., Mortazavi H., Khatami A., Khodashenas Z. Salivary and serum anti-desmoglein 1 and 3 ELISA and indirect im-munofluorescence in pemphigus vulgaris: Correlations with serum elisa, indirect immunofluorescence and disease severity. Acta Dermatovenerol. Croat. 2018;26:91&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">29989863</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaili N., Mortazavi H., Kamyab-Hesari K., Aghazadeh N., Daneshpazhooh M., Khani S., Chams-Davatchi C. Diagnostic ac-curacy of BP180 NC16a and BP230-C3 ELISA in serum and saliva of patients with bullous pemphigoid. Clin. Exp. Dermatol. 2015;40:324&#x2013;330. doi: 10.1111/ced.12510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ced.12510</ArticleId><ArticleId IdType="pubmed">25476471</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallaji Z., Mortazavi H., Lajevardi V., Tamizifar B., Amirzargar A., Daneshpazhooh M., Chams-Davatchi C. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: Correlation with phenotype and severity. J. Eur. Acad. Dermatol. Venereol. 2010;24:275&#x2013;280. doi: 10.1111/j.1468-3083.2009.03408.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-3083.2009.03408.x</ArticleId><ArticleId IdType="pubmed">19709345</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd A.L., Ng W.-Y., Lee Y.S., Loke K.Y., Thai A.C. Evidence of autoantibodies to glutamic acid decarboxylase in oral fluid of type 1 diabetic patients. Diabetes Res. Clin. Pract. 2002;57:171&#x2013;177. doi: 10.1016/S0168-8227(02)00059-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-8227(02)00059-1</ArticleId><ArticleId IdType="pubmed">12126766</ArticleId></ArticleIdList></Reference><Reference><Citation>Markopoulos A.K., Belazi M.A., Drakoulakos D. Glutamic acid decarboxylase autoantibodies in saliva of children with type 1 diabetes. Diabetes Res. Clin. Pract. 1997;38:169&#x2013;172. doi: 10.1016/S0168-8227(97)00078-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-8227(97)00078-8</ArticleId><ArticleId IdType="pubmed">9483382</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiberti C., Shashaj B., Verrienti A., Vecci E.G., Lucantoni F., Masotti D., Morano S., Sulli N., Dotta F. GAD and IA-2 autoantibody detection in type 1 diabetic patient saliva. Clin. Immunol. 2009;131:271&#x2013;276. doi: 10.1016/j.clim.2008.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2008.12.002</ArticleId><ArticleId IdType="pubmed">19162555</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C., Hou X., Li M., Wang L., Zeng P., Jia H., Chen J., Wei Y., He H., Liu X., et al. Detection of AMA-M2 in human saliva: Potentials in diagnosis and monitoring of primary biliary cholangitis. Sci. Rep. 2017;7:796. doi: 10.1038/s41598-017-00906-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00906-1</ArticleId><ArticleId IdType="pmc">PMC5429755</ArticleId><ArticleId IdType="pubmed">28400582</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer J.M., Doshi M., Kirby J.A., Yeaman S.J., Bassendine M.F., Jones D.E.J. Secretory autoantibodies in primary biliary cirrhosis (PBC) Clin. Exp. Immunol. 2000;122:423&#x2013;428. doi: 10.1046/j.1365-2249.2000.01403.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2000.01403.x</ArticleId><ArticleId IdType="pmc">PMC1905785</ArticleId><ArticleId IdType="pubmed">11122250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikuno N., Mackay I.R., Jois J., Omagari K., Rowley M.J. Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 2001;16:1390&#x2013;1394. doi: 10.1046/j.1440-1746.2001.02624.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1440-1746.2001.02624.x</ArticleId><ArticleId IdType="pubmed">11851838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajdani M., Mortazavi N., Besharat S., Mohammadi S., Amiriani T., Sohrabi A., Norouzi A., Edris G. Serum and salivary tissue transglutaminase IGA (tTG-IGA) level in celiac patients. BMC Gastroenterol. 2022;22:375. doi: 10.1186/s12876-022-02456-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-022-02456-x</ArticleId><ArticleId IdType="pmc">PMC9357310</ArticleId><ArticleId IdType="pubmed">35933327</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellagambi F.G., Lomonaco T., Salvo P., Vivaldi F., Hangou&#xeb;t M., Ghimenti S., Biagini D., Di Francesco F., Fuoco R., Errachid A. Saliva sampling: Methods and devices. An overview. TrAC Trends Anal. Chem. 2020;124:115781. doi: 10.1016/j.trac.2019.115781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trac.2019.115781</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawes C. Circadian rhythms in human salivary flow rate and composition. J. Physiol. 1972;220:529&#x2013;545. doi: 10.1113/jphysiol.1972.sp009721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1972.sp009721</ArticleId><ArticleId IdType="pmc">PMC1331668</ArticleId><ArticleId IdType="pubmed">5016036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng V., Koh D., Mok B., Lim L.P., Yang Y., Chia S.E. Stressful life events of dental students and salivary immunoglobulin A. Int. J. Immunopathol. Pharmacol. 2004;17:49&#x2013;56. doi: 10.1177/03946320040170S209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03946320040170S209</ArticleId><ArticleId IdType="pubmed">15345192</ArticleId></ArticleIdList></Reference><Reference><Citation>Challacombe S.J., Percival R.S., Marsh P.D. Age-related changes in immunoglobulin isotypes in whole and parotid saliva and serum in healthy individuals. Oral Microbiol. Immunol. 1995;10:202&#x2013;207. doi: 10.1111/j.1399-302X.1995.tb00143.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-302X.1995.tb00143.x</ArticleId><ArticleId IdType="pubmed">8602331</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>